EHA 2022 – Wojciech Jurczak

Wojciech Jurczak outlines what can be achieved with the current standard treatments in the setting of follicular lymphoma, which findings have been observed for PI3K inhibitor therapy in the TIDAL study and were we are today with respect to CAR-T cell therapy for patients with follicular lymphoma.

Here is the full EHA 2022 report.